Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.
about
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodiesFamilial inflammatory Sneddon's syndrome-case report and review of the literature.APS and the brain.Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus.Hyperactivity in a mouse model of the antiphospholipid syndrome.Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series.Antiphospholipid syndrome: the reality and implications.The impact of gender on clinical manifestations of primary antiphospholipid syndrome.The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosusRecurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus.A case of cerebral infarction associated with positive antiphospholipid antibody in a systemic lupus patient.Hepatic infarction in a pregnant patient with the 'primary' antiphospholipid syndrome.Spectrum of clinical manifestations of antiphospholipid antibodies in childhood and adolescence.Peripheral vascular disease in patients with systemic lupus erythematosus.Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serumControversies in lupus: nervous system involvement.Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.Migraine and haemostasis.The neuropathology and pathogenesis of systemic lupus erythematosus.Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus.CNS dysfunction in the antiphospholipid syndrome.Thrombosis in systemic lupus erythematosus: a French collaborative studyAnticardiolipin antibody.Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke.Migraine and antiphospholipid antibodies.Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancyAntiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosusAntiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.Endosomal vesicles as vehicles for viral genomesCurrent concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE)Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus.Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying 'membrane stress syndrome' hypothesis.What do we really know about autoantibody abnormalities and reproductive failure: a critical review.Nervous system lupus: pathogenesis and rationale for therapy.Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
P2860
Q24805595-32FCC841-1AE2-41A9-AD02-C41FE5E8FE68Q30955669-EDA1E57C-D326-4BF6-946F-8C6B05772854Q33196667-B0A4D009-F599-4C1E-923F-273DBDD0D760Q33251075-465C3FEA-8DFC-47CA-A14A-D6DBD2566C2FQ33338363-C9BF952A-D2CE-443D-9EEF-DFF1415C9E79Q33358817-0E04C785-56CA-4D3B-9398-3D0F3221815EQ33366891-3456A5AC-4050-44DA-8B02-A6FD704F8AFEQ33368554-FBEA1274-9A60-4A79-BB07-F121AB82A0C4Q33371184-CE09108F-45B3-47C8-8272-381EB8CA79C5Q33388232-59B2478B-D055-4FBE-BC88-8D7959355F9FQ33401106-BB8AAF87-822B-4B60-B7B4-6F4D135F01C2Q33491733-D52E1FBF-3919-4D4A-BE39-B4A030CDFBA5Q33493322-913BB116-9E80-4AF4-9700-8C1D752C0A71Q33493445-AAB1A5A4-6F5C-4309-8C01-6B5233EDD30FQ33564222-E393A0FC-24CA-4189-81B1-5DE6DE555C17Q33564647-7834D5C9-1B5E-4335-A4FF-475A75D06AA7Q33567067-1FB22F2C-9DD7-46E1-A9F2-E65C73DD9ABEQ34213820-8943BA53-CDCF-4564-9756-9A9B79497057Q34352811-DD64DD1C-1EFA-42C1-AB0D-5FBDC15EAAC1Q34680879-FD6BBEA0-34ED-433C-9C1A-07C43A205E7CQ35185887-E647A324-663A-43D7-9D45-AD88149D3F71Q35189292-F3206FA7-AC12-413A-9CD1-6272604426D1Q35625220-E5EAB4C5-6CBB-4D06-B17A-9D057351ECC0Q35625224-F59029E2-AE6F-4AB0-90E8-4225BFFCE89AQ35626838-3DD7F0FB-69F7-4A9D-9F32-F44C7487C650Q35719544-7E95BD71-91D7-485E-A34C-20BF7B740A13Q35867162-C82D24E8-5967-447B-8B2B-534A1A9B306AQ36070612-1A95AAE8-9001-41EC-A122-05DA01CE3EB2Q36081533-0EC42593-F13D-46FD-B512-F9EBAB6E1B55Q37045158-6CC04542-C783-4B67-B0DB-B7C1DF6136C9Q37231485-84302B80-A696-4ABA-9F97-7AF04D7FD2ECQ37358421-96D9FD14-45F4-49DE-ADCA-E06C83BA0928Q38205560-7F33518D-5D28-41FB-86DC-6771EE87C4ACQ38660157-4527746E-1004-438C-9C0D-85BBBAA02413Q38841201-EC71D057-7320-4551-A019-ACD8F65A33C3Q39596714-F0D86CAC-97E9-413F-8E0E-9FC677A69DC3Q40583128-F050F9FC-E40C-4855-8B76-E3A73471D108Q40751043-3FA23314-1468-4B0F-B57C-4824A1D63118Q40929944-058C76F2-7464-49D7-B00E-75FCAABCC149Q41156101-6ACC88C8-E8E2-43A7-81F6-BDF85F0484C2
P2860
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Cerebrovascular disease and an ...... ary antiphospholipid syndrome.
@en
type
label
Cerebrovascular disease and an ...... ary antiphospholipid syndrome.
@en
prefLabel
Cerebrovascular disease and an ...... ary antiphospholipid syndrome.
@en
P2093
P50
P1476
Cerebrovascular disease and an ...... ary antiphospholipid syndrome.
@en
P2093
P304
P356
10.1016/0002-9343(89)90335-5
P407
P577
1989-04-01T00:00:00Z